OOIR: Observatory of International Research

Papers

(The TQCC of Nephrology Dialysis Transplantation is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
MO192ASYMPTOMATIC HYPERURICEMIA AS A RISK FACTOR OF OUTCOME IN CARDIORENAL PATIENTS	139
MO589PLASMA CONCENTRATIONS OF TRIMETHYLAMINE N-OXIDE, AND ITS DIETARY DETERMINANTS ARE ASSOCIATED WITH INCREASED RISK OF GRAFT FAILURE	121
MO885APP BASED DOCUMENTATION AND SUPPORT OF A GERMAN HOME DIALYSIS PROGRAMM - A PILOT STUDY	106
MO995DO THE TIMELINE AND SPECTRUM OF INFECTIONS CHANGE AFTER ANTI-REJECTION THERAPY IN KIDNEY TRANSPLANT RECIPIENTS?	102
MO269INCREASED RISK OF DEATH IN PATIENTS WITH DOUBLE POSITIVE SEROLOGY OF ANTI-GLOMERULAR BASE MEMBRANE (ANTI-GBM) ANTIBODIES AND ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA)	86
FC 074POOLED EFFICACY AND CARDIOVASCULAR SAFETY RESULTS OF 3 PLACEBO-CONTROLLED AND 1 DARBEPOETIN ALFA-CONTROLLED STUDIES OF ROXADUSTAT FOR TREATMENT OF ANAEMIA IN PATIENTS WITH NON-DIALYSIS-DEPENDENT	83
MO184ANTICOAGULANT THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION	83
MO443EFFECTS OF SHORT-TERM POTASSIUM CHLORIDE SUPPLEMENTATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE*	80
MO295RESULTS OF 30 YEARS OF RENAL BIOPSIES IN THE GENERAL HOSPITAL OF CIUDAD REAL. WHAT HAS CHANGED?	78
FC 122BONE DENSITOMETRY IN RENAL TRANSPLANTED PATIENTS	67
MO873THE STRUCTURE OF DEATH IN PATIENTS WITH ESRD ON DIALYSIS	65
MO210SERUM LEVELS OF PLASMINOGEN ACTIVATOR UROKINASE RECEPTOR AND CARDIOTROPHIN-LIKE CYTOKINE FACTOR 1IN PATIENTS WITH NEPHROTIC SYNDROME	59
MO336RENAL CONTRAST-ENHANCED ULTRASOUND (CEUS) TO EVALUATE EARLY AND CHRONIC MODIFICATIONS OF RENAL PERFUSION AND TO PREDICT RENAL DYSFUNCTION AFTER RENAL ISCHEMIA-REPERFUSION IN MICE	55
MO390THE RISK FACTORS AND CLINICAL OUTCOMES ASSOCIATED WITH ACUTE KIDNEY INJURY IN PATIENTS WITH COVID-19	51
FC 047COMPARISON OF THE CHARACTERISTICS AND MORTALITY OF ACUTE KIDNEY INJURY IN PATIENTS WITH COVID-19 AND OTHER RESPIRATORY INFECTIONS: A PROSPECTIVE COHORT STUDY	50
MO214EVALUATION OF THE EFFECT OF A POTASSIUM BINDER ON ARRHYTHMIA-RELATED CARDIOVASCULAR OUTCOMES IN PATIENTS ON CHRONIC HAEMODIALYSIS WITH RECURRENT HYPERKALAEMIA: DESIGN AND RATIONALE FOR THE SODIUM	48
MO939RECURRENCE AND OUTCOME OF ANTI-GLOMERULAR BASEMENT MEMBRANE GLOMERULONEPHRITIS AFTER KIDNEY TRANSPLANTATION: A BELGIAN MULTICENTER STUDY	48
FC 102PD INDUCED ARTERIOLAR AND PERITONEAL PATHOMECHANISMS ARE PARTIALLY REVERSED AFTER KIDNEY TRANSPLANTATION	44
MO510OLFACTORY AND GUSTATORY DYSFUNCTION AMONG PATIENTS WITH KIDNEY IMPAIRMENT	42
MO938PATIENT SURVIVAL AFTER LIVING DONOR KIDNEY DONATION	42
MO212: Updated Interim Results of A Phase 1/2 Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Activity of BION-1301 in Patients With IGA Nephropathy	41
FC051: Atacicept Reduces Serum ANTI-GD-IGA1 Levels in IgAN Patients	39
MO220: Comparison of the Effects of Hydroxychloroquine and Glucocorticosteroids on Immunological Parametrs in Patients with IGA Nephropathy	39
FC005: Pace CKD: Qualitative and Quantitative Insights into the Economic Burden of CKD on Patients and Carers	38
#4519 CAN WE REPLACE URINE TESTING AND DELIVER A STEP CHANGE IN ACCESS TO RENOPROTECTIVE MEDICATIONS?	38

MO704THE PROGNOSTIC IMPACT OF WEIGHT GAIN AFTER PERITONEAL DIALYSIS	37
MO645BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH TYPE 2 DIABETES MELLITUS WITH AND WITHOUT DIABETIC NEPHROPATHY	36
MO100: Alectinib-Induced Reversible Acute Kidney Injury	36
MO733RISK FACTORS FOR INFECTIVE ENDOCARDITIS IN PATIENTS RECEIVING HAEMODIALYSIS- A PROPENSITY MATCHED COHORT STUDY	35
MO693EXERCISE TOLERANCE AND NUTRITIONAL STATUS PREDICTS ALL-CAUSE MORTALITY IN OLDER ADULTS ON PERITONEAL DIALYSIS: A SINGLE-CENTER PROSPECTIVE OBSERVATIONAL COHORT STUDY	35
MO506RELATIONSHIP BETWEEN SODIUM CONSUMPTION, PRO-INFLAMMATORY PARAMETERS AND KIDNEY DISEASE IN THE JACKSON HEART STUDY	34
MO979: Influence of BK Virus Plasma Viral Load in Kidney Transplant Outcomes	33
MO611CARDIOPULMONARY RESERVE EXAMINED WITH CARDIOPULMONARY EXERCISE TESTING IN INDIVIDUALS WITH AND WITHOUT CHRONIC KIDNEY DISEASE; A SYSTEMATIC REVIEW AND META-ANALYSIS	33
MO697TUBERCULOUS PERITONITIS WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS: A CASE REPORT	33
MO844COVID-19 PANDEMIC IN DIALYSIS PATIENTS IN SWITZERLAND	33
#5619 THE ASSOCIATION BETWEEN THE LEVELS OF URIC ACID AND RENAL OUTCOMES IN EARLY CKD PATIENTS: A MULTI-CENTER REAL-WORLD DATA ANALYSIS	32
#4845 EFFECT OF OMEGA-3 FATTY ACID ON MITOCHONDRIAL MEMBRANE FATTY ACID AND COMPARISON WITH ERYTHROCYTE MEMBRANE IN ADENINE INDUCED UREMIC RATS	32
#6470 PATIENT SURVIVAL IN AN ASSOCIATED VASCULITIS COHORT – DATA FROM A REFFERAL CENTER	32
#4127 MODULATION OF BLOOD PRESSURE THROUGH MICROBIOME EXCHANGE BETWEEN MILAN NORMOTENSIVE AND HYPERTENSIVE STRAINS OF RATS	32
#3667 REVEAL-CKD: PREVALENCE OF UNDIAGNOSED STAGE 3 CHRONIC KIDNEY DISEASE IN AUSTRALIA, BRAZIL, CANADA AND SPAIN	31
#5479 EXPLORING CANADIAN PATIENT EXPERIENCES OF LIVING WITH LUPUS NEPHRITIS	31
#5147 PREDICTING NON-DIABETIC KIDNEY DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: EXTERNAL VALIDATION OF FOUR PREDICTIVE MODELS	30
#6754 THE EFFECT OF REDUCED RENAL FUNCTION ON SEXUAL DYSFUNCTION IN PATIENTS WITH HEART FAILURE	30
#3372 HOST RESPONSE CHANGES ASSOCIATED WITH PERSISTENT ACUTE KIDNEY INJURY IN CRITICALLY ILL PATIENTS WITH COVID-19	29
#4264 PERITONEAL DIALYSIS AFTER FAILED KIDNEY TRANSPLANT: A SUITABLE OPTION	29
#3045 EFFICACY AND SAFETY OF MONTHLY-STEROID PULSE THERAPY AND TONSILLECTOMY IN PATIENTS WITH IGA NEPHROPATHY	28
#4877 THE EFFECT OF NURSE-LED 8-ZONE LUNG ULTRASOUND GUIDED TITRATION OF DRY WEIGHT ON HYPERTENSION IN APPARENTLY EUVOLAEMIC HAEMODIALYSIS PATIENTS	28
#3282 ASSOCIATION OF PROLONGED QT INTERVALS WITH MORTALITY IN HEMODIALYSIS PATIENTS: A NATIONWIDE RETROSPECTIVE COHORT STUDY	27
#3421 MRI PREDICTORS OF DIASTOLIC DYSFUNCTION OF THE LEFT VENTRICLE	27
#4758 IMPACT OF GENDER ON CHRONIC KIDNEY DISEASE IN ELDERLY	27
#5730 PERLECAN AS A POTENTIAL BIOMARKER OF CARDIOVASCULAR RISK: ROLE OF ENDOTHELIAL GLYCOCALYX IN CHRONIC KIDNEY DISEASE	27
#4673 POLY(I:C) INDUCES MORPHOLOGICAL CHANGES AND TYPE I INTERFERON-MEDIATED INFLAMMATORY RESPONSE IN MESOTHELIAL CELLS FROM PERITONEUM	26
#3971 INJURY INDUCED RENAL FIBROSIS PROMOTES CYSTOGENESIS AND CYST GROWTH IN ADULT MICE WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE	26
#6399 ROLE OF THERAPEUTIC PLASMAPHERESIS IN PAUCI-IMMUNE VASCULITIS – A SINGLE CENTRE EXPERIENCE	25
#3697 FAMILIAL PAPILLARY RENAL CELL CARCINOMA: A CASE REPORT	25
#3812 ARE KIDNEY CYSTS MORE COMMON IN PEOPLE WITH COL4A3/COL4A4 PATHOGENIC VARIANTS?	25
#4869 ULTRASOUND IMAGING PATTERNS OF KIDNEY DISEASE IN PATIENTS WITH METABOLIC SYNDROME	25
#5633 USE OF HEPARIN GRAFTED DIALYZER (EVODIAL) FOR HEMODIALYSIS IN PATIENTS WITH HIGH RISK OF BLEEDING: A SINGLE CENTER EXPERIENCE	24
#4317 CLINICAL DIVERSITY OF STEROID-RESISTANT NEPHROTIC SYNDROME CAUSED BY TRPC6 MUTATIONS	24
#4141 SERUM BICARBONATE AND CKD PROGRESSION: A LONGITUDINAL ANALYSIS BY THE GROUP-BASED TRAJECTORY MODEL	24
#6829 DIFFERENTIAL LIPIDIC PROFILE WITH THE USE OF CITRATE OR ACETATE DIALYSATES	24
#4027 KIDNEY INJURY MOLECULE 1 (KIM-1): A POTENTIAL BIOMARKER OF ACUTE KIDNEY INJURY AND TUBULOINTERSTITIAL INJURY IN PATIENTS WITH ANCA-GLOMERULONEPHRITIS	22
#2950 IGA NEPHROPATHY: PUTTING THE A IN THE UNACQUAINTED	22
#4617 THE IMPACT OF DONOR NEPHRECTOMY ON THE ELDERLY LIVING KIDNEY DONORS	22
#3207 KIDNEY FUNCTION ESTIMATORS FOR DRUG DOSE ADJUSTMENT OF DIRECT ORAL ANTICOAGULANTS IN OLDER ADULTS WITH ATRIAL FIBRILLATION	22
#6352 CLINICAL AND MOLECULAR SPECTRUM OF V-LESION	22
#5555 TAKAYASU ARTERITIS IN THE TIME OF SARS-COV-2	22
#5785 ACUTE KIDNEY INJURY AS A RISK FACTOR FOR THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE AND MORTALITY IN HOSPITALIZED PATIENTS	22
#3069 CIRCULATING SCLEROSTIN AFFECTS URINARY CALCIUM EXCRETION AMONG STONE FORMERS	22
#5157 ESTIMATION OF RENAL KT/V FROM 24-HOUR URINE VOLUME AND UREA DISTRIBUTION VOLUME IN PERITONEAL DIALYSIS	22
#2754 EPIDEMIOLOGY OF PAUCI-IMMUNE ANCA-ASSOCIATED GLOMERULONEPHRITIS – REPORT FROM AN AUSTRALIAN POPULATION-BASED STUDY	22
#3408 A META-ANALYSIS OF VASCULAR ACCESS OUTCOMES IN HEMODIALYSIS PATIENTS OVER 75 YEARS OF AGE	21
#5517 IN CHRONIC KIDNEY DISEASE, IRON DEFICIENCY-INDUCED ANEMIA IS ASSOCIATED WITH HIGHER LEVELS OF FGF23 THAT ARE NOT REDUCED BY IRON ADMINISTRATION	21
#6286 NEPHROCALCINOSIS IN 3 GENERATIONS OF FEMALE PATIENTS DUE TO A PATHOGENIC MEN1 MUTATION	21
#5018 EFFECTS OF CANDESARTAN COMPARED TO LOSARTAN ON INHIBITING MESANGIAL EXPANSION IN DIABETIC MODEL RATS RECEIVING ROSMARINIC ACID	21

#5615 VALIDITY AND ADEQUACY OF ANIMAL MODELS IN HAEMODIALYSIS RESEARCH: A SYSTEMATIC REVIEW	21
#6340 TUBULOINTERSTITIAL NEPHRITIS: DIFFERENT SIDES OF THE SAME COIN	21
#5624 REMDESIVIR IN COVID-19 PATIENTS WITH KIDNEY DISEASE: A STUDY ON THE RENAL FUNCTION AND OUTCOMES	21
#6649 SIGNIFICANT CLINICAL IMPROVEMENT OF PAEDIATRIC AND ADULT PATIENTS WITH DISTAL RENAL TUBULAR ACIDOSIS AFTER 6 YEARS OF TREATMENT WITH SIBNAYAL®	20
#4662 MSC-DERIVED EXOSOMES PREVENT PERITONEAL FIBROBLAST TRANSDIFFERENTIATION IN PERITONEAL DIALYSIS-ASSOCIATED PERITONEAL FIBROSIS	20
#5745 CORRELATION BETWEEN MATRIX GLA PROTEIN LEVEL AND EFFECT OF VITAMIN K2 THERAPY ON VASCULAR CALCIFICATION IN HEMODIALYSIS PATIENTS	20
#6605 A CASE REPORT OF MEMBRANOUS NEPHROPATHY SECONDARY TO SYPHILIS: A STEROID-RESPONSIVE DISEASE?	19
#3243 CANCER PATIENTS WITH END-STAGE KIDNEY DISEASE ON CHRONIC HEMODIALYSIS: CHANGING THE PARADIGM	19
#3144 KIDNEY TRANSPLANT-RELATED KNOWLEDGE AMONG SOUTH ASIAN COMPARED TO WHITE CANADIAN PATIENTS	19
#5591 CIRCULATING ACTIVIN A REFLECTS THE SEVERITY OF RENAL FIBROSIS IN BIOPSY-PROVEN KIDNEY DISEASES—THE TAIPEI RENAL BIOPSY COHORT STUDY	19
#6279 ESKD TREATMENTS: A DIFFICULT CHOICE TO ELDERLY PATIENTS?	19
#3715 THE EFFECT OF DAPRODUSTAT ON INTRAVENOUS IRON USE IN PATIENTS WITH CKD-RELATED ANAEMIA ON DIALYSIS IN THE ASCEND TRIALS	18
#5548 THE PROGNOSTIC VALUE OF LYMPHOCYTE SUBSETS IN ANTIBODY RESPONSE AFTER SARS-COV2 VACCINATION IN DIALYSIS PATIENTS AND KIDNEY TRANSPLANT RECIPIENTS	18
#6733 THE PREDICTORS OF CARDIO-RENAL SYNDROME AMONG PATIENTS WITH COVID-19 INFECTION	18
#5599 FEBUXOSTAT IN COMBINATION WITH ANAKINRA OR PH NEUTRALIZATION IMPROVE THE OUTCOMES IN HYPERURICEMIA-RELATED URIC ACID CRYSTALLURIA IN MICE	18
#5674 HYPERURICEMIA AND HIGH URINARY URIC ACID LEVELS ARE THE NEW EARLY PREDICTORS OF CONTRAST-ASSOCIATED ACUTE KIDNEY INJURY	18
#3853 THE EFFECT OF PERITONEAL CAVITY FLUSHING ON ACID BASE BALANCE OF PERITONEAL DIALYSIS PATIENTS	18
#2728 THROMBOINFLAMMATORY BIOMARKERS AND THEIR RELATIONSHIP WITH CIRCULATING GLYCOSAMINOGLYCANS IN END-STAGE RENAL DISEASE PATIENTS	18
#3336 EFFECTS OF LIPID-LOWERING DRUGS ON IMPROVING KIDNEY FUNCTION: A DRUG TARGET MENDELIAN RANDOMIZATION STUDY	18
#3822 POLYOMAVIRUS INFECTION MONITORING BY QUANTITATIVE PCR IN KIDNEY RECIPIENTS AS AN INSTRUMENT FOR PREVENTING POSTTRANSPLANT COMPLICATIONS	18
#3023 KARYOMEGALIC INTERSTITIAL NEPHRITIS SECONDARY TO FAN1 VARIANTS: CHARACTERIZATIONS AND OUTCOMES. RESULTS OF THE FAN1 STUDY GROUP	18
#4295 SPECTRUM OF GLOMERULAR AND VASCULAR KIDNEY PATHOLOGY ASSOCIATED WITH MYELOPROLIFERATIVE NEOPLASMS	17
#3271 EXPRESSION OF THE COLLAGEN IV α345 MOLECULE ALONG THE RENAL TUBULE IN HEALTH AND DISEASE	17
#3618 CLINICAL SIGNIFICANCE OF MILD ABNORMALITIES IN GLOMERULAR FILTRATION BARRIER (GBM) DIAGNOSED BY RENAL BIOPSY	17
#4850 20 YEARS' EXPERIENCE OF PERITONEAL DIALYSIS IN SARAWAK, MALAYSIA	17
#4011 LESSONS LEARNT FROM VIRTUAL RECRUITMENT TO A MULTICENTRE RANDOMISED CONTROLLED TRIAL EVALUATING A DIGITAL HEALTH INTERVENTION FOR CKD	17
#5608 THE INFLUENCE OF AMBULATORY BP ON THE ASSOCIATIONS OF SEX WITH CARDIOVASCULAR EVENTS AND MORTALITY IN DIALYSIS PATIENTS: A PROSPECTIVE COHORT STUDY	17
#4412 URINARY SODIUM-TO-POTASSIUM RATIO DOES NOT ACCURATELY REFLECT DIETARY SODIUM-TO-POTASSIUM RATIO	17
#5209 ALGALSIDASE-BETA STABILIZES RENAL AND CARDIAC INVOLVEMENT: A FOLLOW-UP STUDY OF A BRAZILIAN FABRY DISEASE FAMILY	17
#5863 A NOVEL SELF-SEALING DIALYSIS PORT EVALUATION	17
#5443 ASSOCIATION OF SERUM CALCIUM-TO-MAGNESIUM RATIO WITH CARDIOVASCULAR AND CEREBRAL VASCULAR DISEASES IN DIALYSIS PATIENTS	17
#6904 EVALUATION OF KIDNEY FUNCTION GRAPH SURVEILLANCE ACROSS SOUTH WEST WALES, UK	17
#6668 PREDICTION OF REMAINING RENAL FUNCTION IN PATIENTS UNDERGOING RADICAL NEPHRECTOMY DUE TO RENAL TUMOUR MASS AND AFTER NEPHRECTOMY IN LIVING DONORS	17
#3113 BURDEN OF KIDNEY DISEASES IN THE GENERAL POPULATION OF THE VAL VENOSTA/VINSCHGAU DISTRICT	17
#6879 ASSOCIATION OF THE BERDEN CLASSIFICATION AND THE PROGNOSIS OF ANCA VASCULITIS	17
#6749 PREVALENCE, AWARENESS, TREATMENT, AND CONTROL OF HYPERTENSION IN OLDER ADULTS WITH CHRONIC KIDNEY DISEASE: THE IRISH LONGITUDINAL STUDY ON AGEING	16
#5958 VALUE OF EXOME SEQUENCING “FIRST” FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE	16
#4303 REDUCING FRAILTY IN HEMODIALYSIS PATIENTS THROUGH INTRADIALYTIC VIRTUAL REALITY EXERCISE INTERVENTION: THE REVID STUDY	16
#6467 DETERMINANTS OF NON-DIABETIC KIDNEY DISEASES IN DIABETIC PATIENTS	16
#2845 TOLVAPTAN TREATMENT FOR THREE YEARS SIGNIFICANTLY IMPROVED RENAL PROGNOSIS IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENTS	16
#2948 β-2-MICROGLOBULIN AND β-TRACE-PROTEIN DO NOT IMPROVE ESTIMATION OF GFR IN KIDNEY TRANSPLANT RECIPIENTS COMPARED TO CREATININE AND CYSTATIN C	16
#2868 PREDICTION OF MAJOR GASTROINTESTINAL BLEEDING EVENTS IN HEMODIALYSIS	16
#4018 CHARACTERISATION OF THE CLINICAL, HUMANISTIC AND ECONOMIC BURDEN OF ANAEMIA IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC LITERATURE REVIEW	16
#3665 DCR2 PROMOTES TUBULAR MALADAPTIVE REPAIR BY INHIBITING KETONE BODY–INDUCED FOXO3 SIGNALING AFTER ACUTE KIDNEY INJURY	16
#5974 CLINICAL AND HISTOPATHOLOGICAL CHARACTERISTICS OF THE ONCONEPHROLOGICAL POPULATION: A MULTICENTRE PROSPECTIVE OBSERVATIONAL STUDY	16
#6658 ORAL HEALTH STATUS IN DIABETIC AND NON-DIABETIC PATIENTS ON MAINTENANCE HEMODIALYSIS TREATMENT	15
#3641 DOES IBANDRONATE OR CALCIUM AND VITAMIN D MAINTAIN OR IMPROVE BONE MICROARCHITECTURE IN THE FIRST YEAR AFTER KIDNEY TRANSPLANTATION?	15
#6579 ANALYSIS OF RISK FACTORS FOR CUTANEOUS CALCIPHYLAXIS IN HEMODIALYSIS PATIENTS	15
#3560 STATIN THERAPY IN CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING HAEMODIALYSIS	15
#3471 INCIDENCE, RISK FACTORS AND OUTCOMES ASSOCIATED WITH ACUTE KIDNEY INJURY IN COVID-19 AT THE NATIONAL KIDNEY AND TRANSPLANT INSTITUTE	15
#4184 MALE CHRONIC KIDNEY DISEASE IS A STATE OF PREMATURE TESTICULAR AGING	15
#4032 RAPAMYCIN AGGRAVATES KIDNEY LESIONS IN RATS FED HIGH PHOSPHATE	15
#4470 THE IMPACT OF RESIDUAL NATRIURESIS ON INTRADIALYTIC HYPERTENSION IN PATIENTS ON ISONATRIC DIALYSIS: A MONOCENTRIC STUDY AT THE FRANCK JOLY HOSPITAL CENTER	15
#3841 ASSOCIATION BETWEEN BODY MASS INDEX, WAIST CIRCUMFERENCE AND CLINICAL OUTCOMES IN KOREAN ADVANCED CHRONIC KIDNEY DISEASE PATIENTS	15
#3556 ASSOCIATION OF SERUM 25-HYDROXYVITAMIN D WITH ALL-CAUSE MORTALITY AND KIDNEY OUTCOME IN PATIENTS WITH EARLY STAGES OF CKD	15
#4913 ANALYSIS OF THE LIPID PROFILE IN THE RENAL PATIENT AND SUB-ANALYSIS OF THE POPULATION WITH POLYCYSTIC KIDNEY DISEASE	15
#4472 POLYMORPHISMS OF THE GENE FOR GALECTIN-3 IN PATIENTS IN THE TERMINAL PHASE OF RENAL INSUFFICIENCY	15
#4063 APELIN INCREASES FOREARM BLOOD FLOW IN CHRONIC KIDNEY DISEASE	15
#5448 INCIDENCE OF ACUTE PULMONARY EDEMA AFTER THE SYSTEMATIC USE OF ULTRASOUND B-LINES	15
#6848 DIABETES AND HEMODIALYSIS ARTERIOVENOUS ACCESS CONSTRUCTION – A RETROSPECTIVE STUDY IN A SINGLE CENTER	15
#5960 MORBIDITY AND MORTALITY OF SARS-COV-2 POSITIVE HOSPITALISED HEMODIALYSIS PATIENTS IN CASE OF CENTRALIZED ORGANIZATIONAL STRUCTURE IN HEALTHCARE	14
#2686 15-YEAR TEMPORAL CHANGES IN RATES OF ACUTE KIDNEY INJURY AMONG CHILDREN: A POPULATION-BASED COHORT STUDY	14
#3922 CLINICOPATHOLOGICAL CHARACTERISTICS OF LIGHT AND HEAVY CHAIN DEPOSITION DISEASE: A CASE SERIES FROM A SINGLE CENTER	14
#3823 CAN HLA MOLECULAR MISMATCH GUIDE CLINICAL DECISION IN PAEDIATRIC KIDNEY TRANSPLANT RECIPIENTS: A RETROSPECTIVE STUDY	14
#6120 MIRNA PROFILING OF URINARY EXTRACELLULAR VESICLES (EVS) IN TBMN AND CFHR5 NEPHROPATHY FOR THE IDENTIFICATION OF NOVEL DISEASE BIOMARKERS	14
#5868 PREVALENCE AND MANAGEMENT OF CHRONIC COMPLICATIONS IN PATIENTS WITH DIABETES AND ADVANCED CHRONIC KIDNEY DISEASE: A RETROSPECTIVE AUDIT	14
#5527 ALDOSTERONE, CORTISOL AND URINE VOLUME CAN EXPLAIN DISCREPANCIES BETWEEN DIETARY AND URINARY NA/K RATIO	14
#4383 WHEN SHOULD WE TRY TREATMENT FOR PERITONEAL SCLEROSIS?	14
#6128 IMPACT OF MANNOSE-BINDING LECTIN DEFICIENCY ON GRAFT SURVIVAL IN TRANSPLANT RECIPIENTS WITH IGAN	14
#6682 RENAL ARTERY STENOSIS: A SINGLE CENTRE STUDY	14
#4447 EFFECT OF RENAL IMPAIRMENT ON IPTACOPAN PHARMACOKINETICS	14
#6648 LONG TERM EFFECT OF MEDIUM CUT-OFF DIALYZER ON MIDDLE UREMIC TOXINS	14
#6530 WHAT IS IMPORTANT IN PRIMARY CARDIORENAL INTERACTION SYNDROME	14
#4281 TERTIARY HOSPITAL EXPERIENCE IN AN ESSENTIAL SUBSPECIALTY: ONCONEPHROLOGY	14
#2892 CRITICAL ROLE OF SERUM RESPONSE FACTOR IN PODOCYTE EPITHELIAL–MESENCHYMAL TRANSITION OF DIABETIC NEPHROPATHY	14
#2984 ACHIEVED BLOOD PRESSURE AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH ADVANCED STAGE CHRONIC KIDNEY DISEASE	14
#2560 HEMOGLOBIN VARIABILITY AND ADVERSE CLINICAL EVENTS IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE AND ANEMIA IN CONTINUOUS CARE	14
#4773 INFECTIVE ENDOCARDITIS COMPLICATED BY RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS: BEYOND ANTIBIOTICS - TO TREAT OR NOT TO TREAT?	14
#3369 THE EFFECT OF ACUPRESSURE APPLIED TO DIFFERENT FISTULA AREA ON FISTULE NEEDLE ENTRY PAIN	14
#4884 DISRUPTION OF THE INTESTINAL MUCOSAL BARRIER IN CHRONIC KIDNEY DISEASE IS RELATED TO REDUCED EXPRESSION OF THE TIGHT JUNCTIONS' COMPONENTS	13

#4271 THE GROWING BURDEN OF CHRONIC KIDNEY DISEASE IN THE UK: AN IMPACT CKD ANALYSIS	13
#6891 MACHINE LEARNING NEPHROPATHOLOGY DIAGNOSTICS OF THROMBOTIC MICROANGIOPATHIES	13
#4980 THE ROLE OF EARLY ACUTE KIDNEY REPLACEMENT THERAPY (AKRT) IN THE PROGNOSIS OF PATIENTS WITH COVID-19: A RANDOMIZED CLINICAL TRIAL	13
#6292 PSYCHOLOGICAL CHALLENGES OF THE PATIENT STARTING PERITONEAL DIALYSIS	13
#3976 THE ROLE OF GENDER DIFFERENCES AND MENOPAUSE IN OBESITY-RELATED RENAL DISEASE, RENAL INFLAMMATION AND LIPOTOXICITY	13
#6672 THE DEVELOPMENT OF A COMMUNITY-NEPHROLOGY, MULTI-DISCIPLINARY SERVICE	13
#4776 RENAL RESERVE ASSESSMENT IN PATIENTS WHO UNDERWENT DONOR NEPHRECTOMY OVER A 15-YEAR FOLLOW-UP PERIOD AND COMPARISON WITH 2 OTHER PATIENTS	13
#5906 THE PROGNOSTIC VALUE OF DIFFERENT HISTOPATHOLOGIC MODELS OF ANCA-ASSOCIATED VASCULITIDES: A PROSPECTIVE STUDY	13
#6456 DSA-NEGATIVE MICROVASCULAR INFLAMMATION IN KIDNEY TRANSPLANT BIOPSIES: GENE EXPRESSION COMPARISON WITH NATIVE AND TRANSPLANT KIDNEY CONTROLS	13
#2599 LONG-TERM LONGITUDINAL CHANGES OF PULSE WAVE VELOCITY AND THEIR ASSOCIATION TO CARDIOVASCULAR RISK FACTORS IN MAINTENANCE HEMODIALYSIS PATIENTS	13
#5522 USING THE KIDNEY FAILURE RISK EQUATION TO PREDICT END-STAGE KIDNEY DISEASE IN CKD PATIENTS OF SOUTH ASIAN ETHNICITY: AN EXTERNAL VALIDATION STUDY	13
#5352 INCIDENT ACUTE KIDNEY INJURY AND THE RISK OF DEMENTIA: THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT	13
#2775 USING A DEEP LEARNING MODEL TO EVALUATE PATHOLOGICAL INJURY OF DIABETIC KIDNEY DISEASE	13
#5304 ACCURACY OF PLATELET INDICES AS PREDICTOR OF IN-HOSPITAL MORTALITY IN PATIENTS WITH ACUTE KIDNEY INJURY REQUIRING RENAL REPLACEMENT THERAPY	13
#3940 RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS ACCORDING TO DIALYSIS MODALITY	13
#5346 RE-ASSESSMENT OF PATHOLOGICAL DATA OF VASCULITIS PATIENTS WITH RENAL INVOLVEMENT ACCORDING TO CURRENT SCORING SYSTEMS AND CLINICAL CORRELATION	13
#4752 EMERGENCY DEPARTMENT VISITS IN PERITONEAL DIALYSIS PATIENTS: A SINGLE CENTER STUDY DURING AN 8-YEAR PERIOD	13
#6032 LONG-TERM OUTCOMES IN A COHORT OF PATIENTS WITH SYSTEMIC VASULITIDES (SV) AND KIDNEY INVOLVEMENT	13
#2525 THE 2021 CKD EPI GLOMERULAR FILTRATION RATE ESTIMATING EQUATION AND RISK OF HOSPITALIZATION FOR KIDNEY DISEASE	12
#3988 MARS – A NOVEL SCORE TO PREDICT THE RISK OF ACUTE KIDNEY INJURY AFTER LIVING DONOR LIVER TRANSPLANT	12
#3640 IMMUNORELATED RENAL ADVERSE EFFECTS IN PATIENTS TREATED WITH CHECKPOINT INHIBITORS	12
#2765 EVALUATION OF ANTIBODY RESPONSES TO SARS-COV-2 VACCINES IN PATIENTS WITH CKD	12
#3546 “SURPRISE QUESTION”: IS IT A USEFUL TOOL IN CKD STAGES 4 TO 5?	12
#2938 DE NOVO DSA IS ASSOCIATED WITH HUMAN PERIPHERAL BLOOD CXCR5+PD-1+CD8+ T CELLS AND PD-1 PD-L1 MRNA EXPRESSION IN KIDNEY TRANSPLANT PATIENTS	12
#6180 OXALATE NEPHROPATHY SECONDARY TO ENTERIC HYPEROXALURIA: A RARE CAUSE OF END STAGE RENAL FAILURE – A REPORT OF 2 CASES	12
#4210 ZETOMIPZOMIB DEMONSTRATES CLINICALLY MEANINGFUL IMPROVEMENT IN UPCR IN NEPHROTIC RANGE PROTEINURIA PATIENTS: RESULTS FROM THE OPEN-LABEL MISSION STUDY	12
#2808 REMDESIVIR FOR MODERATE-TO-SEVERE COVID-19 PNEUMONIA IN MAINTENANCE DIALYSIS PATIENTS: A RETROSPECTIVE COHORT STUDY	12
#4183 A PHENOTYPIC DRIVEN RITUXIMAB MAINTENANCE APPROACH IS EFFECTIVE AND SAFE IN PATIENTS WITH ANCA ASSOCIATED VASCULITIS	12
#2531 AGATSTON INDEX AS A PREDICTOR OF PREDICTION OF THE DEGREE OF HEART VASCULAR DAMAGE IN STAGE 5 CKD PATIENTS RECEIVING PROGRAM HEMODIALYSIS	12
#6863 MANAGEMENT AND OUTCOMES OF SEPSIS ASSOCIATED ACUTE KIDNEY INJURY IN CRITICALLY ILL PATIENTS	12
#2568 LONG-READ SEQUENCING IDENTIFIES NOVEL PATHOGENIC INTRONIC VARIANTS IN GITELMAN SYNDROME	12
#5532 COVID-19 INFECTION MODIFIES GLOMERULAR DISEASE EVOLUTION	12
#6211 THE OPPORTUNITY COSTS EXPERIENCED BY PATIENTS WHO INJECT DRUGS UNDERGOING HAEMODIALYSIS: A CASE SERIES	12
#6681 MT-TL1 M.3243A>G MITOCHONDRIAL DNA VARIANT DETECTED FROM WHOLE EXOME SEQUENCING CAN EXPLAIN CASES OF ADULT UNKNOWN NEPHROPATHIES	12
#5195 MORTALITY OF PATIENTS ON CHRONIC HEMODIALISYS: CAUSED OR RELATED TO SARS-COV-2 INFECTION?	12
#6522 CYSTATIN C-BASED ESTIMATED GLOMERULAR FILTRATION RATE AND RISK OF STROKE IN THE GENERAL POPULATION	12
#3261 SAR131675, A SELECTIVE VEGFR3 INHIBITOR, AMELIORATES RENAL INFLAMMATION AND LYMPHANGIOGENESIS IN THE MURINE LUPUS NEPHRITIS MODEL	12
#2652 ANTIPROTEINURIC EFFECT OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS IN GLOMERULAR AND SYSTEMIC DISEASES: A REAL-WORLD CLINICAL STUDY	12
#4973 PATHOGENIC ROLE OF D313Y MUTATION IN FABRY DISEASE	12
#5817 EPIDEMIOLOGY OF CHRONIC KIDNEY DISEASE AND COMORBID ILLNESS IN OLDER HOSPITALIZED PATIENTS	12
#2502 THE FREQUENCY AND RISK FACTORS OF NODAT AND ELECTROLYTE DISORDERS IN KIDNEY TRANSPLANT PATIENTS	11
#6009 MUSCLE OXYGENATION AND MICROVASCULAR REACTIVITY ACROSS DIFFERENT STAGES OF CHRONIC KIDNEY DISEASE: A NEAR-INFRARED SPECTROSCOPY STUDY	11
#5535 CALCIUM EXCRETION FRACTION AS AN EMERGING PARAMETER FOR AN ACCURATE DIFFERENTIAL DIAGNOSIS OF ACUTE KIDNEY INJURY	11
#6915 IMMUNOLOGIC EFFECTS OF THE DECREASE OF IMMUNOSUPPRESSION AFTER SARS-COV-2 INFECTION IN KIDNEY TRASPLANT RECIPIENTS	11
#4098 PATIENT ACUITY AND CARDIOVASCULAR OUTCOME IN HEMODIALYSIS PATIENTS: A KOREAN NATIONWIDE COHORT STUDY	11
#6368 PLATELET TO LYMPHOCYTE RATIO AND SICKLE CELL NEPHROPATHY	11
#3617 APPLICATION OF CKD EPI 2021 EQUATION FOR ESTIMATION OF GLOMERULAR FILTRATION RATE (EGFR) TO AN ELDERLY KOREAN COHORT TO PREDICT MORTALITY	11
#5462 METABOLIC PROFILING IN CHILDREN WITH END STAGE RENAL DISEASE ON PERITONEAL DIALYSIS: PRELIMINARY RESULTS OF AN ONGOING PRESPECTIVE STUDY	11
#6158 UREMIC TOXINS ARE ASSOCIATED WITH IMMUNE-SENESCENCE AND IMMUNE-EXHAUSTION IN HEMODIALYSIS PATIENTS	11
#4238 UNEXPLAINED METABOLIC ACIDOSIS - A DIAGNOSTIC DILEMMA	11
#5635 SYSTEMIC OXALOSIS: AN OVERVIEW OF THE FINDINGS AND PREVALENCE IN PRIMARY HYPEROXALURIA	11
#4188 PREFERENCES FOR PROGNOSTIC INFORMATION PROVISION AMONGST PATIENTS WITH CHRONIC KIDNEY DISEASE: A SURVEY	11
#4966 CELLULAR PRION PROTEIN ACTIVATES THE TBK1-IRF3 SIGNALING PATHWAY TO AGGRAVATE RENAL FIBROSIS	11
#4583 NEUROLOGICAL DISEASES TREATED WITH PLASMAPHERESIS PERFORMED BY NEPHROLOGISTS	11
#6113 SCRATCHING THE SURFACE? A LONGITUDINAL OBSERVATIONAL STUDY ON PRURITUS AND ITS CURRENT TREATMENT IN INCIDENT DIALYSIS PATIENTS	11
#6881 ELEVATED LEVELS OF THE C5B9 TERMINAL COMPLEMENT COMPLEX IN PATIENTS RECEIVING RENAL REPLACEMENT THERAPY	11
#6719 ACUTE KIDNEY INJURY AND MULTIPLE MYELOMA-THE ROLE CYTOGENETICS: A COHORT STUDY	11
#3055 ASSOCIATION OF MORTALITY WITH INTRADIALYTIC EXERCISE IN HEMODIALYSIS PATIENTS	11
#2787 HOSPITAL MANAGEMENT OF AN INTEGRATED CLINICAL PRACTICE UNIT OF VASCULAR ACCESS FOR HEMODIALYSIS: A CHALLENGE FOR IMPROVING HEALTHCARE QUALITY?	11
#3958 PROTON PUMP INHIBITORS AND THE RISK OF ACUTE KIDNEY INJURY IN PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS: A POPULATION-BASED COHORT STUDY	11
#5825 REAL WORLD EVALUATION OF SGLT2 INHIBITORS IN PATIENTS WITH DIABETIC NEPHROPATHY AND HEART FAILURE: THE EFFECT ON THE DIASTOLIC DYSFUNCTION	11
#3968 DIFFERENCES IN MENTAL HEALTH STATUS DURING COVID-19 PANDEMIC BETWEEN IN-CENTER HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS	11
#3934 SAFETY AND EFFICACY OF EVOLOCUMAB AMONG KIDNEY TRANSPLANT PATIENTS AT HIGH CARDIOVASCULAR RISK	11
#6036 CYSTIC KIDNEY PHENOTYPE IS A FREQUENT, AGE- AND EGFR- DEPENDENT FINDING IN ALPORT SYNDROME	11
#3658 PERITONEAL INFLAMMATION INDUCES SYSTEMIC ERYPTOSIS IN PERITONEAL DIALYSIS-ASSOCIATED PERITONITIS	11
#3836 DETERMINATION OF PREDICTORS OF OUTCOMES FOLLOWING VASCULAR ACCESS CONVERSION: WHICH PATIENTS BENEFIT MOST?	11
#6797 EFFICACY OF DESENSITIZATION TREATMENT IN HYPERIMMUNIZED PATIENTS AWAITING A CADAVERIC KIDNEY TRANSPLANTATION	11
#3062 ROLE OF ONLINE HEMODIAFILTRATION (OL-HDF) IN THE CONTINUOUS MEASUREMENT OF THE DIALYSIS DOSE	11
#5895 HOSPITAL-ACQUIRED INFECTIONS IN HOSPITALIZED PATIENTS WITH ACUTE KIDNEY INJURY: A RETROSPECTIVE COHORT STUDY	11
#3798 A MULTICENTER CLINICAL STUDY OF CELLULOSE TRIACETATE MEMBRANES AND POLYSULFONE MEMBRANE DIALYZERS IN MAINTENANCE HEMODIALYSIS PATIENTS	11
#2556 BIOLOGICAL EFFECTS OF A SHORT PERIOD OF NORMOTHERMIC MACHINE PERFUSION IN MARGINAL KIDNEYS: RESULTS OF A PROTEOMICS ANALYSIS	11
#6896 A SCREENING AND CLINICAL MANIFESTATIONS OF FABRY DISEASE IN PATIENTS ATTENDING DIALYSIS AND NEPHROLOGY CLINICS IN DURBAN, SOUTH AFRICA	11
#4623 A NOVEL ELECTRO-HYDRAULIC ACOUSTIC THERAPY REDUCES BLOOD PRESSURE IN HYPERTENSIVE PATIENTS WITH CHRONIC KIDNEY DISEASE: PRELIMINARY RESULTS	10
#5645 SHORT-CHAIN FATTY ACIDS, PROPIONATE AND BUTYRATE, RESEMBLE THE BENEFICIAL EFFECTS OF VITAMIN D DURING ACUTE KIDNEY DAMAGE	10
#5411 CARDIO-FISTULA RECIRCULATION REDUCTION IN OLDER ADULTS: IT'S NOT THAT EASY	10
#4176 ROLE OF KIDNEY FUNCTION ON NRF2 MRNA LEVELS IN TYPE-2 DIABETES	10
#5718 ASSOCIATION OF MULTIPLE PLASMA BIOMARKER LEVELS WITH KIDNEY DISEASE ACTIVITY IN FABRY DISEASE	10
#5121 IGM POSITIVE MINIMAL CHANGE DISEASE: CHARACTERIZING DISEASE SEVERITY AND OUTCOMES	10
#6431 THE DEVELOPMENT OF AN INTEGRATED COMMUNITY, CONSERVATIVE KIDNEY CARE AND PALLIATIVE-RENAL CARE SERVICE	10
#3525 TRANSITION BETWEEN NUTRITION CATEGORIES IN HEMODIALYSIS PATIENTS	10
#3193 PERFORMANCE OF THE RACE-FREE CKD-EPI CREATININE-BASED EGFR EQUATION IN A DANISH COHORT WITH CHROMIUM-51-EDTA CLEARANCE MEASUREMENTS	10
#5648 RIPK3 MEDIATES KIDNEY INJURY INDUCED BY A CYTOKINE STORM	10
#5510 CKD-ASSOCIATED PRURITUS SEVERITY AND ITS ASSOCIATION WITH BODY DISTRIBUTION AND EQ-5D HEALTH-RELATED QUALITY OF LIFE IN HAEMODIALYSIS PATIENTS	10
#3419 LINARIN PROTECTS THE KIDNEY FROM ISCHEMIA-REPERFUSION INJURY AND SUPPRESSES ETS2 INDUCED ACUTE KIDNEY INJURY	10
#5089 EVALUATION OF REMOTE MONITORING OF HAEMODIALYSIS VASCULAR ACCESS FOR PREDICTION OF STENOSIS AND THROMBOTIC VASCULAR EVENTS	10
#6569 PREDICTION OF ALL-CAUSE MORTALITY FOR CHRONIC KIDNEY DISEASE PATIENTS USING FOUR MODELS OF MACHINE LEARNING	10
#5503 PIOGLITAZONE REVERSES MIR-130A AND MIR-199 DYSREGULATION INDUCED BY TGF-BETA DURING KIDNEY FIBROSIS	10
#5146 KINETIC ESTIMATION OF GFR AND URINARY CREATININE EXCRETION RATE AS PREDICTORS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANTS FROM DECEASED DONORS	10
#3379 DESIGN OF A NEW DIAPHRAGM PRESSURE TRANSDUCER FOR DIALYSIS MACHINE	10
#3676 EVALUATION OF HAEMOGLOBIN RESPONSE IN PATIENTS WITH CKD-RELATED ANAEMIA NOT ON DIALYSIS RECEIVING DAPRODUSTAT OR CONTROL IN ASCEND-ND	10
#4743 OMNIGRAF (COMBINED GENE EXPRESSION AND DD-CF DNA) USE IN MONITORING RENAL ALLOGRAFT REJECTION IN MULTIORGAN TRANSPLANT RECIPIENTS	10
#2648 IMPACT OF ACUTE AND CHRONIC KIDNEY FUNCTION ON THE SIZE AND PROGNOSIS OF ISCHEMIC STROKE AFTER THROMBECTOMY	10
#6698 THROMBOPROPHYLAXIS IN PEDIATRIC KIDNEY TRANSPLANTATION: A META-ANALYSIS	10
#6442 HOW CAN IT BE NEPHROANGIOSCLEROSIS? HE´S BEING TREATED ONLY WITH ONE ANTIHYPERTENSIVE DRUG	10
#3314 DIURETIC AND RENOPROTECTIVE EFFECTS OF GOREISAN IN A RAT MODEL OF NEPHROTIC SYNDROME	10